Answers are grounded in this paper and cite their sources.
Follicular helper T cells (T FH ) are critical for vaccine and infection elicitation of long-lived humoral immunity, but exaggerated T FH responses can promote autoimmunity and other pathologies. It is unfortunate that no clinical interventions exist for the selective depletion of follicular T cells to alleviate these diseases. We engineered a chimeric antigen receptor (CAR) facilitating the specific targeting of cells with high expression levels of human programmed cell death protein 1 (PD-1), a cardinal feature of follicular T cells. CAR-expressing human natural killer (NK) cells robustly and discriminately eliminated PD-1 high follicular human T cells in vitro and in a humanized mouse model of lupus-like disease while sparing B cells and other PD-1 low T cell subsets, including regulatory T cells. These results establish a strategy for specific targeting of PD-1 high T cells that can be advanced as a clinical tool for the selective depletion of pathogenic follicular T cells or other PD-1 high target cells in certain disease states.
No takes yet. Share an insight, caveat, or question.
Reighard et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: